1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.

Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Glenmark Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Expensive Performer
Download real time

1405.15 -17.15 (-1.21%)

59.13% Gain from 52W Low

337.6K NSE+BSE Volume

NSE 13 Mar, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
Medium Financial Strength
40.0 / 100
Valuation Score
Expensive Valuation
10.8 / 100
Momentum Score
Technically Neutral
39.1 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
1,688
1Yr Price target upside is 20%
13 analysts

12

S

9

W

4

O

1

T

SWOT Analysis

Glenmark Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

19 Feb, 2025 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
17 Feb, 2025 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
17 Feb, 2025 TRENDLYNE
Glenmark Pharmaceuticals Results Earnings Call for Q3FY25
Glenmark Pharmaceuticals Results Earnings Call for Q3FY25
video link
21 Nov, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
18 Nov, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
18 Nov, 2024 TRENDLYNE
Glenmark Pharmaceuticals Results Earnings Call for Q2FY25
Glenmark Pharmaceuticals Results Earnings Call for Q2FY25
video link
20 Aug, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
16 Aug, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
31 May, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Audio Recording Of The Glenmark Pharma…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Audio Recording Of The Glenmark Pharma…
pdf link
29 May, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
27 May, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
27 May, 2024 TRENDLYNE
Glenmark Pharmaceuticals Results Earnings Call for Q4FY24
Glenmark Pharmaceuticals Results Earnings Call for Q4FY24
audio video link
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
20 Mar, 2024 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Long-term rating upgraded to 'CRISIL AA/Stable'; Removed from \u2018Watch Positive\u2019; Short-term rating reaffirmed
link
22 Feb, 2024 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Long-term rating continues on 'Watch Positive\u2019; Short-term rating reaffirmed
link
21 Dec, 2023 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Long-term rating continues on 'Watch Positive'; Short-term rating reaffirmed
link
03 Oct, 2023 INDIA RATINGS
India Ratings Places Glenmark Pharmaceuticals Bank Facilities on Rating Watch w…
link
28 Sep, 2023 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Long term rating placed on 'Watch Positive'; Short-term rating reaffirmed
link
27 Apr, 2023 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Ratings Reaffirmed
link
25 Jan, 2023 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Rating outlook revised to 'Stable'; Ratings reaffirmed
link
15 Dec, 2022 INDIA RATINGS
India Ratings Revises Glenmark Pharmaceuticalss Outlook to Stable; Affirms IND …
link
23 Dec, 2021 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Rating outlook revised to 'Positive'; Ratings reaffirmed
link
27 Oct, 2021 INDIA RATINGS
Correction: India Ratings Revises Glenmark Pharmaceuticals Outlook to Positive;…
link
22 Oct, 2021 INDIA RATINGS
India Ratings Revises Glenmark Pharmaceuticals Outlook to Positive; Affirms IND…
link
19 Aug, 2021 CRISIL RATINGS
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited:Ratings reaffirmed at 'CRISIL AA- / Stable / CRISIL A1+ '
link
All Credit Ratings
14 Feb, 2025 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
14 Nov, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
14 Aug, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
30 May, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
24 May, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
14 Feb, 2024 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
10 Nov, 2023 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
21 Sep, 2023 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
11 Aug, 2023 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
19 May, 2023 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
10 Feb, 2023 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link
17 Nov, 2022 BSE INDIA
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR…
pdf link

Glenmark Pharmaceuticals Ltd. FAQ

How is Glenmark Pharmaceuticals Ltd. today?
Glenmark Pharmaceuticals Ltd. today is trading in the red, and is down by -1.21% at 1405.15.
Glenmark Pharmaceuticals Ltd. is currently trading down -1.21% on an intraday basis. In the past week the stock rose 0.60%. stock has been down -7.44% in the past quarter and rose 56.40% in the past year. You can view this in the overview section.